Associate Director, Clinical Operations (Therapeutics/Oncology)

Location: Cambridge, Massachusetts, United States; 70% in-office and 30% flexible work model

Salary: $142,500–$256,500 per year, plus potential bonus, incentive compensation, or equity.

Company

hirify.global develops mRNA-based therapeutics and vaccines using its mRNA technology, delivery, and manufacturing platforms.

What you will do

• Lead clinical trials from first-in-human through Phase 4 across the therapeutics and oncology portfolio.
• Develop clinical operations strategies and plans aligned with clinical development programs.
• Manage study budgets, timelines, resources, invoices, forecasting, and operational risks.
• Select and oversee CROs, vendors, clinical sites, and outsourced trial activities.
• Collaborate with Clinical, Regulatory, CMC, Biostatistics, Data Management, Finance, and Program Management teams.
• Provide oversight and mentorship to Clinical Trial Managers and Clinical Trial Associates.

Requirements

• BA/BS degree and 8–10 years of clinical trial or clinical program experience, including at least 4 years of independent trial management.
• Full clinical trial lifecycle experience, including start-up, conduct, and closure.
• Robust therapeutics and oncology experience; early clinical development and immuno-oncology experience are desirable.
• Experience with GCP inspections, audits, clinical documents, operational compliance, and regulatory requirements.
• Strong leadership, communication, organizational, collaboration, and problem-solving skills in biotech or pharmaceutical environments.
• Some travel is required.

Nice to have

• Advanced degree.
• Experience with hematologic malignancies.
• Experience building relationships with key opinion leaders.

Culture & Benefits

• Competitive healthcare and voluntary benefit programs.
• Fitness, mindfulness, and mental health resources.
• Family planning support, including fertility, adoption, and surrogacy benefits.
• Paid vacation, volunteer days, sabbatical, recharge days, and year-end shutdown.
• Savings and investment programs plus location-specific benefits.
• In-person collaboration supported by a 70/30 work model.